Axsome Therapeutics, Inc.
AXSM
Revenue
196.00M
▲25.01M▲14.62%
3 Months ChangeAssets
689.81M
▲20.56M▲3.07%
3 Months ChangeLiabilities
601.51M
▲5.99M▲1.01%
3 Months ChangeFree Cash Flow
-43.71M
▲9.85M▲18.39%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001193125-26-062421
2026-02-17
Form 8-K
ID: 0001193125-26-053009
2026-01-12
Form 8-K
ID: 0001193125-26-009744
2025-12-31
Form 8-K
ID: 0001193125-25-337644
2025-11-03
Form 10-Q
ID: 0001193125-25-262664
2025-11-03
Form 8-K
ID: 0001193125-25-261651
2025-08-20
Form 8-K
ID: 0001579428-25-000007
2025-08-04
Form 10-Q
ID: 0000950170-25-102148
2025-08-04
Form 8-K
ID: 0000950170-25-101624
2025-06-10
Form 8-K
ID: 0000950170-25-084098